NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to slow ALS progression in early trial
Disease control Not yet recruitingThis early-stage trial tests an oral drug called Kamlanoflast in 40 people with ALS. The goal is to see if it is safe, tolerable, and can reduce inflammation or slow functional decline over 24 weeks. Participants must be 18-75 years old, diagnosed with ALS within the last 3 years…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Eccentric cycling: a new spin on MS rehab?
Symptom relief Not yet recruitingThis study tests a new exercise called eccentric cycling for people with multiple sclerosis. Researchers want to see if it improves muscle strength, walking, fatigue, and quality of life better than standard training. The study plans to enroll 60 adults with MS who can walk indep…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC